Merck KGaA inaugurated a new, state-of-the-art packaging center at its headquarters in Darmstadt, Germany.
This new state-of-the-art packaging center uses the latest technological advances to serves the patients in a better way.
The new 15, 000 square meters facility will be dedicated to the packaging and shipping of the companies medicines in more than 90 countries.
It will help to meet increasing patient needs for flagship medicines Glucophage®, Concor® and Euthyrox® in the areas of diabetes, cardiovascular diseases and thyroid disorders respectively.
It will also provide capacity for potential future Pharma products currently in clinical development such as evobrutinib in the area of neurology-immunology or tepotinib in the area of oncology.
The new packaging center will have the capacity to process more than 210 million boxes of medicines every year, with its eight fully automated packaging lines and robotised logistics.
It is designed to incorporate a broad range of new technologies such as the tracking & tracing of medicines to prevent counterfeit, or smart packaging to ensure more flexibility to adapt the production of medicines to patient demand.
The new packaging center is also designed to comply with the highest international standards in terms of quality, environment, health and safety.